Celera has discovered associations between genetic variations and the risk for progression to cirrhosis in people chronically infected with hepatitis C virus. Other variants predict the risk of progression from non-alcoholic fatty liver disease (NAFLD) to cirrhosis in people who are obese or diabetic.